N-glycoprotein analysis discovers new up-regulated glycoproteins in colorectal cancer tissue

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4932-4941

  Nicastri, Annalisa ^a   Gaspari, Marco ^a   Sacco, Rosario ^a   Elia, Laura ^a   Gabriele, Caterina ^a   Romano, Roberto ^a   Rizzuto, Antonia ^a   Cuda, Giovanni ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

18O stable isotope labeling; biomarker discovery; colorectal cancer; N linked glycoproteins

Indexed keywords

GLYCOPROTEIN; OXYGEN 18; STABLE ISOTOPE; OXYGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MALE; MIDDLE AGED; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE STUDY; UPREGULATION; VERY ELDERLY; BIOLOGY; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION; ITALY; LIQUID CHROMATOGRAPHY; METABOLISM; PHYSIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

BIOMARKERS, TUMOR; CHROMATOGRAPHY, LIQUID; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; ISOTOPE LABELING; ITALY; OXYGEN ISOTOPES; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84908871903     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500647y     Document Type: Article

References (43)

1. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics Ca-Cancer J. Clin. 2011, 61, 69-90
2. de Wit, M.; Kant, H.; Piersma, S. R. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling J. Proteomics 2014, 99, 26-39
3. Bernhard, O. K.; Greening, D. W.; Barnes, T. W.; Ji, H.; Simpson, R. J. Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma Biochim. Biophys. Acta 2013, 1834, 2372-2379
4. Rifai, N.; Gillette, M. A.; Carr, S. A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat. Biotechnol. 2006, 24, 971-983
5. Kulasingam, V.; Diamandis, E. P. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies Nat. Clin. Pract. Oncol. 2008, 5, 588-599
6. McLeod, H. L.; Murray, G. I. Tumour markers of prognosis in colorectal cancer Br. J. Cancer 1999, 79, 191-203
7. de Wit, M.; Fijneman, R. J.; Verheul, H. M.; Meijer, G. A.; Jimenez, C. R. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications Clin. Biochem. 2013, 46, 466-479
8. Hakomori, S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives Cancer Res. 1985, 45, 2405-2414
9. Tian, Y.; Zhang, H. Glycoproteomics and clinical applications Proteomics Clin. Appl. 2010, 4, 124-132
10. Tian, Y.; Zhang, H. Characterization of disease-associated N-linked glycoproteins Proteomics 2013, 13, 504-511
11. Hakomori, S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism Cancer Res. 1996, 56, 5309-5318
12. Li, Q. K.; Gabrielson, E.; Zhang, H. Application of glycoproteomics for the discovery of biomarkers in lung cancer Proteomics Clin. Appl. 2012, 6, 244-256
13. Peracaula, R.; Barrabes, S.; Sarrats, A.; Rudd, P. M.; de Llorens, R. Altered glycosylation in tumours focused to cancer diagnosis Dis. Markers 2008, 25, 207-218
14. Gebauer, G.; Muller-Ruchholtz, W. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance Anticancer Res. 1997, 17, 2939-2942
15. Catalona, W. J.; Smith, D. S.; Ratliff, T. L. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N. Engl. J. Med. 1991, 324, 1156-1161
16. Alberico, S.; Facca, M. C.; Millo, R.; Radillo, L.; Mandruzzato, G. P. Tumoral markers (CA 125-CEA) in the screening of ovarian cancer Eur. J. Gynaecol. Oncol. 1988, 9, 485-489
17. Kolarich, D.; Jensen, P. H.; Altmann, F.; Packer, N. H. Determination of site-specific glycan heterogeneity on glycoproteins Nat. Protoc. 2012, 7, 1285-1298
18. Morelle, W.; Michalski, J. C. Analysis of protein glycosylation by mass spectrometry Nat. Protoc. 2007, 2, 1585-1602
19. Yang, Z.; Hancock, W. S. Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column J. Chromatograph., A 2004, 1053, 79-88
20. Kaji, H.; Saito, H.; Yamauchi, Y. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins Nat. Biotechnol. 2003, 21, 667-672
21. Bayer, E. A.; Ben-Hur, H.; Wilchek, M. Biocytin hydrazide-a selective label for sialic acids, galactose, and other sugars in glycoconjugates using avidin-biotin technology Anal. Biochem. 1988, 170, 271-281
22. Zhang, H.; Li, X. J.; Martin, D. B.; Aebersold, R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry Nat. Biotechnol. 2003, 21, 660-666
23. Yin, X.; Bern, M.; Xing, Q.; Ho, J.; Viner, R.; Mayr, M. Glycoproteomic analysis of the secretome of human endothelial cells Mol. Cell. Proteomics 2013, 12, 956-78
24. Zhou, Y.; Aebersold, R.; Zhang, H. Isolation of N-linked glycopeptides from plasma Anal. Chem. 2007, 79, 5826-5837
25. Kall, L.; Canterbury, J. D.; Weston, J.; Noble, W. S.; MacCoss, M. J. Semi-supervised learning for peptide identification from shotgun proteomics datasets Nat. Methods 2007, 4, 923-925
26. Fenselau, C.; Yao, X. 18O2-labeling in quantitative proteomic strategies: a status report J. Proteome Res. 2009, 8, 2140-2143
27. Johnson, K. L.; Muddiman, D. C. A method for calculating 16O/18O peptide ion ratios for the relative quantification of proteomes J. Am. Soc. Mass Spectrom. 2004, 15, 437-445
28. Pellegrini, P.; Contasta, I.; Berghella, A. M.; Gargano, E.; Mammarella, C.; Adorno, D. Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer Cancer Immunol. Immunother. 2000, 49, 388-394
29. Miles, W. F.; Greig, J. D.; Seth, J.; Sturgeon, C.; Nixon, S. J. Raised carcinoembryonic antigen level as an indicator of recurrent disease in follow up of patients with colorectal cancer Br. J. Gen. Pract. 1995, 45, 287-288
30. Iacovazzi, P. A.; Notarnicola, M.; Caruso, M. G.; Guerra, V.; Frisullo, S.; Altomare, D. F. Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients Immunopharmacol. Immunotoxicol. 2010, 32, 160-164
31. Marti, J.; Fuster, J.; Sola, A. M. Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer World J. Surg. 2013, 37, 1103-1109
32. Sis, B.; Sagol, O.; Kupelioglu, A. Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma Pathol., Res. Pract. 2004, 200, 379-387
33. Randall, J.; Thorne, T.; Delpire, E. Partial cloning and characterization of Slc12a2: the gene encoding the secretory Na+-K+-2Cl-cotransporter Am. J. Physiol. 1997, 273, C1267-C1277
34. Payne, J. A.; Xu, J. C.; Haas, M.; Lytle, C. Y.; Ward, D.; Forbush, B., 3rd. Primary structure, functional expression, and chromosomal localization of the bumetanide-sensitive Na-K-Cl cotransporter in human colon J. Biol. Chem. 1995, 270, 17977-17985
35. Garzon-Muvdi, T.; Schiapparelli, P.; ap Rhys, C. Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation PLoS Biol. 2012, 10, e1001320
36. van der Slot, A. J.; Zuurmond, A. M.; Bardoel, A. F. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis J. Biol. Chem. 2003, 278, 40967-40972
37. Hofbauer, K. H.; Gess, B.; Lohaus, C.; Meyer, H. E.; Katschinski, D.; Kurtz, A. Oxygen tension regulates the expression of a group of procollagen hydroxylases Eur. J. Biochem. 2003, 270, 4515-4522
38. Evens, A. M.; David, K. A.; Helenowski, I. Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era J. Clin. Oncol. 2010, 28, 1038-1046
39. Adachi, M.; Taki, T.; Konishi, T.; Huang, C. I.; Higashiyama, M.; Miyake, M. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression J. Clin. Oncol. 1998, 16, 1397-406
40. Guo, X.; Friess, H.; Graber, H. U. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases Cancer Res. 1996, 56, 4876-4880
41. Gahmberg, C. G.; Tolvanen, M. Why mammalian cell surface proteins are glycoproteins Trends Biochem. Sci. 1996, 21, 308-311
42. Cima, I.; Schiess, R.; Wild, P. Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 3342-3347
43. Cerciello, F.; Choi, M.; Nicastri, A. Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring Clin. Proteomics 2013, 10, 16